| 679168 |
FRONTIERS IN ONCOLOGY |
Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study |
2021-04-20 |
10.3389/fonc.2021.664392 |
Li Shijie, Lu Shiyang, Liu Xuefeng, Chen Xiaonan |
| 679167 |
FRONTIERS IN ONCOLOGY |
The Human Cytomegalovirus US31 Gene Predicts Favorable Survival and Regulates the Tumor Microenvironment in Gastric Cancer |
2021-04-20 |
10.3389/fonc.2021.614925 |
Ye Sisi, Hu Yuanbo, Chen Chenbin, Chen Sian, Tong Xinya, Zhu Huanbo, Deng Bo, Hu Xianjing, Sun Xiangwei, Chen Xiadong, Shi Xinyu, Gu Ruihong, Xie Wangkai, Guo Gangqiang, Xing Dong, Shen Xian, Xue Xiangyang, Shen Shurong |
| 679166 |
FRONTIERS IN ONCOLOGY |
Pyrotinib Combined With Vinorelbine in HER2-Positive Metastatic Breast Cancer: A Multicenter Retrospective Study |
2021-04-20 |
10.3389/fonc.2021.664429 |
Li Yi, Qiu Yixuan, Li Huihui, Luo Ting, Li Wei, Wang Hong, Shao Bin, Wang Biyun, Ge Rui |
| 679165 |
FRONTIERS IN ONCOLOGY |
Efficacy, Safety, and Cost-Minimization Analysis of Continuous Infusion of Low-Dose Gemcitabine Plus Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma |
2021-04-20 |
10.3389/fonc.2021.641975 |
Arrieta Oscar, Muñoz-Montaño Wendy, Muñiz-Hernández Sae, Campos Saul, Catalán Rodrigo, Soto-Molina Herman, Guzmán Vázquez Silvia, Díaz-Álvarez Osvaldo, Martínez-Pacheco Victor, Turcott Jenny G., Ramos-Ramírez Maritza, Cabrera-Miranda Luis, Barrón Feliciano, Cardona Andrés F. |
| 679164 |
FRONTIERS IN ONCOLOGY |
Efficacy of Combination Chemo-Immunotherapy as a First-Line Treatment for Advanced Non-Small-Cell Lung Cancer Patients With HER2 Alterations: A Case Series |
2021-04-20 |
10.3389/fonc.2021.633522 |
Zhao Shuang, Xian Xinghong, Tian Panwen, Li Weimin, Wang Ke, Li Yalun |
| 679163 |
FRONTIERS IN ONCOLOGY |
A Pro-Tumorigenic Effect of Heparanase 2 (Hpa2) in Thyroid Carcinoma Involves Its Localization to the Nuclear Membrane |
2021-04-20 |
10.3389/fonc.2021.645524 |
Margulis Itai, Naroditsky Inna, Gross-Cohen Miriam, Ilan Neta, Vlodavsky Israel, Doweck Ilana |
| 679162 |
FRONTIERS IN ONCOLOGY |
Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer |
2021-04-20 |
10.3389/fonc.2021.662205 |
Rossi Gabriella, Simoni Nicola, Paiella Salvatore, Rossi Roberto, Venezia Martina, Micera Renato, Malleo Giuseppe, Salvia Roberto, Giuliani Tommaso, Di Gioia Anthony, Auriemma Alessandra, Milella Michele, Guariglia Stefania, Cavedon Carlo, Bassi Claudio, Mazzarotto Renzo |
| 679161 |
FRONTIERS IN ONCOLOGY |
STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion |
2021-04-20 |
10.3389/fonc.2021.611081 |
Deng Tuo, He Zihao, Duan Xiaolu, Gu Di, Cai Chao, Wu Wenqi, Liu Yongda, Zeng Guohua |
| 679160 |
FRONTIERS IN ONCOLOGY |
Analysis of the EGFR Amplification and CDKN2A Deletion Regulated Transcriptomic Signatures Reveals the Prognostic Significance of SPATS2L in Patients With Glioma |
2021-04-20 |
10.3389/fonc.2021.551160 |
Wang Haiwei, Wang Xinrui, Xu Liangpu, Zhang Ji, Cao Hua |
| 679159 |
FRONTIERS IN ONCOLOGY |
Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p |
2021-04-20 |
10.3389/fonc.2021.630921 |
Gu Xian, Zhu Ling-yu, Xu Zhen-ye, Shen Ke-ping |
